Works by Asanuma, Hiroko


Results: 34
    1

    Randomized phase II trial of survivin 2B peptide vaccination for patients with HLA‐A24‐positive pancreatic adenocarcinoma.

    Published in:
    Cancer Science, 2019, v. 110, n. 8, p. 2378, doi. 10.1111/cas.14106
    By:
    • Shima, Hiroaki;
    • Tsurita, Giichiro;
    • Wada, Satoshi;
    • Hirohashi, Yoshihiko;
    • Yasui, Hiroshi;
    • Hayashi, Hiroshi;
    • Miyakoshi, Takashi;
    • Watanabe, Kazue;
    • Murai, Aiko;
    • Asanuma, Hiroko;
    • Tokita, Serina;
    • Kubo, Terufumi;
    • Nakatsugawa, Munehide;
    • Kanaseki, Takayuki;
    • Tsukahara, Tomohide;
    • Nakae, Yutaka;
    • Sugita, Osamu;
    • Ito, Yoichi M.;
    • Ota, Yasunori;
    • Kimura, Yasutoshi
    Publication type:
    Article
    2

    Immunohistological analysis of pancreatic carcinoma after vaccination with survivin 2B peptide: Analysis of an autopsy series.

    Published in:
    Cancer Science, 2019, v. 110, n. 8, p. 2386, doi. 10.1111/cas.14099
    By:
    • Kubo, Terufumi;
    • Tsurita, Giichiro;
    • Hirohashi, Yoshihiko;
    • Yasui, Hiroshi;
    • Ota, Yasunori;
    • Watanabe, Kazue;
    • Murai, Aiko;
    • Matsuo, Kazuhiko;
    • Asanuma, Hiroko;
    • Shima, Hiroaki;
    • Wada, Satoshi;
    • Nakatsugawa, Munehide;
    • Kanaseki, Takayuki;
    • Tsukahara, Tomohide;
    • Mizuguchi, Toru;
    • Hirata, Koichi;
    • Takemasa, Ichiro;
    • Imai, Kohzoh;
    • Sato, Noriyuki;
    • Torigoe, Toshihiko
    Publication type:
    Article
    3

    Autocrine HGF/c-MET signaling in prostate cancer stem-like cells/cancer-initiating cells. Prostate adenocarcinoma tissue was stained by anti-SOX2 and anti-HGF antibodies. HGF is expressed in prostate adenocarcinoma tissue.

    Published in:
    Cancer Science, 2013, v. 104, n. 4, p. 00, doi. 10.1111/cas.12104
    By:
    • Nishida, Sachiyo;
    • Hirohashi, Yoshihiko;
    • Torigoe, Toshihiko;
    • Inoue, Ryuta;
    • Kitamura, Hiroshi;
    • Tanaka, Toshiaki;
    • Takahashi, Akari;
    • Asanuma, Hiroko;
    • Masumori, Naoya;
    • Tsukamoto, Taiji;
    • Sato, Noriyuki
    Publication type:
    Article
    4
    5
    6

    Novel spliced form of a lens protein as a novel lung cancer antigen, Lengsin splicing variant 4.

    Published in:
    Cancer Science, 2009, v. 100, n. 8, p. 1485, doi. 10.1111/j.1349-7006.2009.01187.x
    By:
    • Nakatsugawa, Munehide;
    • Hirohashi, Yoshihiko;
    • Torigoe, Toshihiko;
    • Asanuma, Hiroko;
    • Takahashi, Akari;
    • Inoda, Satoko;
    • Kiriyama, Kenji;
    • Nakazawa, Emiri;
    • Harada, Kenji;
    • Takasu, Hideo;
    • Tamura, Yasuaki;
    • Kamiguchi, Kenjiro;
    • Shijubo, Noriharu;
    • Honda, Ryoichi;
    • Nomura, Naohiro;
    • Hasegawa, Tadashi;
    • Takahashi, Hiroki;
    • Sato, Noriyuki
    Publication type:
    Article
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20

    Rapid on-site evaluation by endosonographer during endoscopic ultrasound-guided fine needle aspiration for pancreatic solid masses.

    Published in:
    Journal of Gastroenterology & Hepatology, 2013, v. 28, n. 4, p. 656, doi. 10.1111/jgh.12122
    By:
    • Hayashi, Tsuyoshi;
    • Ishiwatari, Hirotoshi;
    • Yoshida, Makoto;
    • Ono, Michihiro;
    • Sato, Tsutomu;
    • Miyanishi, Koji;
    • Sato, Yasushi;
    • Kobune, Masayoshi;
    • Takimoto, Rishu;
    • Mitsuhashi, Tomoko;
    • Asanuma, Hiroko;
    • Ogino, Jiro;
    • Hasegawa, Tadashi;
    • Sonoda, Tomoko;
    • Kato, Junji
    Publication type:
    Article
    21
    22
    23

    Peptide vaccinations elicited strong immune responses that were reboosted by anti-PD1 therapy in a patient with myxofibrosarcoma.

    Published in:
    Cancer Immunology, Immunotherapy, 2020, v. 69, n. 2, p. 189, doi. 10.1007/s00262-019-02455-0
    By:
    • Tsukahara, Tomohide;
    • Watanabe, Kazue;
    • Murata, Kenji;
    • Takahashi, Akari;
    • Mizushima, Emi;
    • Shibayama, Yuji;
    • Kameshima, Hidekazu;
    • Hatae, Ryo;
    • Ohno, Yasuo;
    • Kawahara, Rituko;
    • Murai, Aiko;
    • Nakatsugawa, Munehide;
    • Kubo, Terufumi;
    • Kanaseki, Takayuki;
    • Hirohashi, Yoshihiko;
    • Terui, Takeshi;
    • Asanuma, Hiroko;
    • Hasegawa, Tadashi;
    • Sato, Noriyuki;
    • Torigoe, Toshihiko
    Publication type:
    Article
    24
    25
    26
    27

    High Expression of CD109 Antigen Regulates the Phenotype of Cancer Stem-Like Cells/Cancer-Initiating Cells in the Novel Epithelioid Sarcoma Cell Line ESX and Is Related to Poor Prognosis of Soft Tissue Sarcoma.

    Published in:
    PLoS ONE, 2013, v. 8, n. 12, p. 1, doi. 10.1371/journal.pone.0084187
    By:
    • Emori, Makoto;
    • Tsukahara, Tomohide;
    • Murase, Masaki;
    • Kano, Masanobu;
    • Murata, Kenji;
    • Takahashi, Akari;
    • Kubo, Terufumi;
    • Asanuma, Hiroko;
    • Yasuda, Kazuyo;
    • Kochin, Vitaly;
    • Kaya, Mitsunori;
    • Nagoya, Satoshi;
    • Nishio, Jun;
    • Iwasaki, Hiroshi;
    • Sonoda, Tomoko;
    • Hasegawa, Tadashi;
    • Torigoe, Toshihiko;
    • Wada, Takuro;
    • Yamashita, Toshihiko;
    • Sato, Noriyuki
    Publication type:
    Article
    28

    Ectopically Expressed Variant Form of Sperm Mitochondria-Associated Cysteine-Rich Protein Augments Tumorigenicity of the Stem Cell Population of Lung Adenocarcinoma Cells.

    Published in:
    PLoS ONE, 2013, v. 8, n. 11, p. 1, doi. 10.1371/journal.pone.0069095
    By:
    • Takahashi, Akari;
    • Hirohashi, Yoshihiko;
    • Torigoe, Toshihiko;
    • Tamura, Yasuaki;
    • Tsukahara, Tomohide;
    • Kanaseki, Takayuki;
    • Kochin, Vitaly;
    • Saijo, Hiroshi;
    • Kubo, Terufumi;
    • Nakatsugawa, Munehide;
    • Asanuma, Hiroko;
    • Hasegawa, Tadashi;
    • Kondo, Toru;
    • Sato, Noriyuki
    Publication type:
    Article
    29
    30
    31

    Clinical and immunological evaluation of anti-apoptosis protein, survivin-derived peptide vaccine in phase I clinical study for patients with advanced or recurrent breast cancer.

    Published in:
    Journal of Translational Medicine, 2008, v. 6, p. 1, doi. 10.1186/1479-5876-6-24
    By:
    • Tsuruma, Tetsuhiro;
    • Iwayama, Yuji;
    • Ohmura, Tosei;
    • Katsuramaki, Tadashi;
    • Hata, Fumitake;
    • Furuhata, Tomohisa;
    • Yamaguchi, Koji;
    • Kimura, Yasutoshi;
    • Torigoe, Toshihiko;
    • Toyota, Nobuhiko;
    • Yagihashi, Atsuhito;
    • Hirohashi, Yoshihiko;
    • Asanuma, Hiroko;
    • Shimozawa, Kumiko;
    • Okazaki, Minoru;
    • Mizushima, Yasuhiro;
    • Nomura, Naohiro;
    • Sato, Noriyuki;
    • Hirata, Koichi
    Publication type:
    Article
    32

    Phase I vaccination trial of SYT-SSX junction peptide in patients with disseminated synovial sarcoma.

    Published in:
    Journal of Translational Medicine, 2005, v. 3, p. 1, doi. 10.1186/1479-5876-3-1
    By:
    • Kawaguchi, Satoshi;
    • Wada, Takuro;
    • Ida, Kazunori;
    • Sato, Yuriko;
    • Nagoya, Satoshi;
    • Tsukahara, Tomohide;
    • Kimura, Sigeharu;
    • Sahara, Hiroeki;
    • Ikeda, Hideyuki;
    • Shimozawa, Kumiko;
    • Asanuma, Hiroko;
    • Torigoe, Toshihiko;
    • Hiraga, Hiroaki;
    • Ishii, Takeshi;
    • Tatezaki, Shin-ichiro;
    • Sato, Noriyuki;
    • Yamashita, Toshihiko
    Publication type:
    Article
    33

    Phase I clinical study of anti-apoptosis protein, survivin-derived peptide vaccine therapy for patients with advanced or recurrent colorectal cancer.

    Published in:
    Journal of Translational Medicine, 2004, v. 2, p. 19, doi. 10.1186/1479-5876-2-19
    By:
    • Tsuruma, Tetsuhiro;
    • Hata, Fumitake;
    • Torigoe, Toshihiko;
    • Furuhata, Tomohisa;
    • Idenoue, Satomi;
    • Kurotaki, Takehiro;
    • Yamamoto, Masaaki;
    • Yagihashi, Atsuhito;
    • Ohmura, Tosei;
    • Yamaguchi, Koji;
    • Katsuramaki, Tadashi;
    • Yasoshima, Takahiro;
    • Sasaki, Kazuaki;
    • Mizushima, Yasuhiro;
    • Minamida, Hidetoshi;
    • Kimura, Hiromichi;
    • Akiyama, Morifumi;
    • Hirohashi, Yoshihiko;
    • Asanuma, Hiroko;
    • Tamura, Yasuaki
    Publication type:
    Article
    34